Header Image
  • Superbugs and SuperRisks: What impact will antibiotic resistance have on the capital markets?

    13 October 2016

    3.45pm – 5.30pm

    Aviva Investors, 1 Poultry, London.

    Register at UKSIF events.

    Increasing rates of antimicrobial resistance (AMR) – the result of the emergence and spread of drug-resistant ‘superbugs’ – is an issue of concern to policy-makers, medics and scientists in all parts of the world.

    As microbes – particularly bacteria – become resistant to drugs commonly used to treat them, we face the prospect of a return to a ‘pre-antibiotic era’ of medicine. Where common infections once again become hard or even impossible to treat, and potentially fatal.

    The threat posed by the rise of AMR is significant. Left unchecked, by 2050 drug-resistant infections could be claiming 10 million lives annually (compared to around 700,000 today), with the rise in mortality and morbidity wiping $100 trillion off global GDP.

    This event will reflect on the magnitude of the global threat; recent developments in the emerging global response to it; and the role that the investment community and private sector can play in supporting comprehensive global efforts to reduce its impact.
     
    Speakers include:  

    • Lord Jim O’Neill, formerly Chief Economist of Goldman Sachs, Chairman of Goldman Sachs Asset Management, and until recently Commercial Secretary to HM Treasury. Jim was commissioned in 2014 by the then UK Prime Minister to lead a global policy review looking at the economic aspects of AMR and the nature of the response required.

    Jim will speak about his work in this field, why the issue represents a threat to global economic prosperity and development, and how he believes companies have a crucial role to play in a collaborative response to this global challenge.

    • Dr Jeremy Farrar (tbc), Director of the Wellcome Trust, will provide a doctor’s perspective on the realities of rising drug resistance, and offer insights on the role of the philanthropic sector and global health bodies in addressing these problems.

    Register at UKSIF events.

Back to all events >